Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.
NCT01670370
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG:
R-GemOx
Sponsor
The First Affiliated Hospital with Nanjing Medical University